4D Pharma PLC (LBPS) stock Surges Premarket on Positive Interim Results from its Cancer Study
Gule Rukhsar
March 23, 2022
On March 23, 4D Pharma PLC (LBPS) announced positive interim results from the Phase I/II study for the treatment of Renal Cell Carcinoma (RCC). Consequently,